DocMorris AG (SWX:DOCM)
Switzerland
· Delayed Price · Currency is CHF 4.868
-0.032 (-0.65%)
Mar 6, 2026, 12:41 PM CET
DocMorris AG Revenue
DocMorris AG had revenue of 260.83M CHF in the quarter ending June 30, 2025, with 4.17% growth. This brings the company's revenue in the last twelve months to 1.06B, up 5.93% year-over-year. In the year 2024, DocMorris AG had annual revenue of 1.02B with 4.91% growth.
Revenue (ttm)
1.06B
Revenue Growth
+5.93%
P/S Ratio
0.22
Revenue / Employee
730.56K
Employees
1,454
Market Cap
238.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.02B | 47.58M | 4.91% |
| Dec 31, 2023 | 969.46M | 38.49M | 4.13% |
| Dec 31, 2022 | 930.97M | -795.53M | -46.08% |
| Dec 31, 2021 | 1.73B | 249.57M | 16.90% |
| Dec 31, 2020 | 1.48B | 121.39M | 8.96% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| Newron Pharmaceuticals | 55.93M |
| IVF Hartmann Holding AG | 159.69M |
| COLTENE Holding AG | 240.71M |
| Santhera Pharmaceuticals Holding AG | 49.02M |
DocMorris AG News
- 2 years ago - Online drug retailer DocMorris meets expectations as cost savings help - Reuters
- 2 years ago - Online drug retailer DocMorris trims top end of 2023 outlook - Reuters